Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IM Cannabis Corp. (IMCC : NSDQ)
 
 • Company Description   
IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.

Number of Employees: 55

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.64 Daily Weekly Monthly
20 Day Moving Average: 141,988 shares
Shares Outstanding: 4.04 (millions)
Market Capitalization: $10.68 (millions)
Beta: 2.19
52 Week High: $7.12
52 Week Low: $1.29
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.00% -7.96%
12 Week 87.90% 64.65%
Year To Date 13.25% 6.96%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3606 - 833 SEYMOUR STREET
-
VANCOUVER,A1 V6B 0G4
CAN
ph: 972-54-433-1111
fax: -
maya.l@imcannabis.com http://www.imcannabis.com
 
 • General Corporate Information   
Officers
Oren Shuster - Chief Executive Officer and Chairman
Uri Birenberg - Chief Financial Officer
Moti Marcus - Director
Einat Zakariya - Director
Brian Schinderle - Director

Peer Information
IM Cannabis Corp. (BJCT)
IM Cannabis Corp. (CADMQ)
IM Cannabis Corp. (APNO)
IM Cannabis Corp. (UPDC)
IM Cannabis Corp. (IMTIQ)
IM Cannabis Corp. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44969Q406
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 4.04
Most Recent Split Date: 7.00 (0.17:1)
Beta: 2.19
Market Capitalization: $10.68 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.67
Price/Cash Flow: -
Price / Sales: 0.27
EPS Growth
vs. Year Ago Period: 106.25%
vs. Previous Quarter: 126.09%
Sales Growth
vs. Year Ago Period: -2.69%
vs. Previous Quarter: -8.65%
ROE
06/30/25 - -
03/31/25 - -122.96
12/31/24 - -151.19
ROA
06/30/25 - -
03/31/25 - -11.69
12/31/24 - -19.43
Current Ratio
06/30/25 - -
03/31/25 - 0.72
12/31/24 - 0.67
Quick Ratio
06/30/25 - -
03/31/25 - 0.59
12/31/24 - 0.58
Operating Margin
06/30/25 - -
03/31/25 - -9.10
12/31/24 - -14.93
Net Margin
06/30/25 - -
03/31/25 - -9.10
12/31/24 - -20.10
Pre-Tax Margin
06/30/25 - -
03/31/25 - -11.97
12/31/24 - -23.68
Book Value
06/30/25 - -
03/31/25 - 0.99
12/31/24 - 1.03
Inventory Turnover
06/30/25 - -
03/31/25 - 9.49
12/31/24 - 8.56
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.10
12/31/24 - 0.15
Debt-to-Capital
06/30/25 - -
03/31/25 - 9.02
12/31/24 - 12.90
 

Powered by Zacks Investment Research ©